World first research: Stent coating that fools the body into better acceptance

Research Updates

Our scientists pioneering world first stent coating

There’s no doubt that cardiac implants or stents save lives. Coronary heart disease - a narrowing or blockage of the blood vessels of the heart - kills around 73,000 Britons each year. The NHS estimates there are are an estimated 2.3 million people living with coronary heart sisease in the UK).

The small scaffold stent props open the diseased artery to prevent heart attacks. But because the body treats stents as foreign, the risk of blood clots is ever present. 

Narrowing or blocking of the stented blood can occur in as many as half of all patients. This can cause a relapse of chest pain and other symptoms, and in extreme cases can be fatal. ‘Drug eluting’ stents were made to address this, secreting drugs to lower the risk of re-narrowing, but the trade-off is a higher risk of heart attack due to blood clots forming in the stent.

In a joint project, researchers from the Immunobiology Group and the Translational Reserch and Bioengineering Group, are developing the world’s first stent coating technology that uses a biomimicry approach, fooling the body so that it integrates with the foreign stent. This will hopefully mean in the future doctors will be able to implant stents that are more compatible with the body, leading to better outcomes for cardiac patients, and less subsequent risk of complications and death.

“The problem with the current steel stents is that they are not biocompatible: they are prone to blood clotting and cells don’t like growing on them. That translates to going back to hospital in three to five years. Some people think that’s a reasonable trade-off, to go and get your stent fixed up every few years. Our argument is that we can do better,” says Dr Christina Bursill, Immunobiology Group Leader at the Heart Research Institute.
“This remarkable coating technology achieves a 10-fold reduction in clotting and enhances blood vessel healing after the stent is placed, thereby improving the outcomes of patients undergoing stenting procedures. This result has profound implications for the development of next generation stents with much better clinical outcomes for patients.”

Previous
Next

Related news

Celebrating 30 Years of Discovery

In March 2019, HRI celebrated 30 years since it opened its doors.

Read more

HRI researchers discover how biomechanical thrombus growth is mediated

Following injuries like a nick or cut, platelets that utilise the binding and signaling functions of an integrin called glycoprotein IIb/IIIa, or αIIbβ3, swarm the wound and clump together, forming a ‘plug’ or clot to stop blood loss. This first stage of wound healing is called hemostasis. However, this clumping of platelets can also cause deadly blood clots – thrombosis – which can lead to cardiovascular disorders such as heart attack or stroke.

Read more

HRI scientists pursue implant ‘Holy Grail’

In a world-first discovery, scientists at the Heart Research Institute have developed a high-tech coating that regulates the body’s often severe immune response to synthetic implants. This brings us one step closer to an exciting future where the human body does not reject lifesaving coronary bypass implants. 

Read more